112 related articles for article (PubMed ID: 18062779)
1. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor.
Walter RB; Häusermann P; Raden BW; Teckchandani AM; Kamikura DM; Bernstein ID; Cooper JA
Traffic; 2008 Feb; 9(2):267-79. PubMed ID: 18062779
[TBL] [Abstract][Full Text] [Related]
2. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.
Walter RB; Raden BW; Zeng R; Häusermann P; Bernstein ID; Cooper JA
J Leukoc Biol; 2008 Jan; 83(1):200-11. PubMed ID: 17947393
[TBL] [Abstract][Full Text] [Related]
3. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.
Orr SJ; Morgan NM; Elliott J; Burrows JF; Scott CJ; McVicar DW; Johnston JA
Blood; 2007 Feb; 109(3):1061-8. PubMed ID: 17008544
[TBL] [Abstract][Full Text] [Related]
4. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor.
Ulyanova T; Blasioli J; Woodford-Thomas TA; Thomas ML
Eur J Immunol; 1999 Nov; 29(11):3440-9. PubMed ID: 10556798
[TBL] [Abstract][Full Text] [Related]
5. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
6. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
7. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.
Taylor VC; Buckley CD; Douglas M; Cody AJ; Simmons DL; Freeman SD
J Biol Chem; 1999 Apr; 274(17):11505-12. PubMed ID: 10206955
[TBL] [Abstract][Full Text] [Related]
8. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
10. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity.
Walter RB; Raden BW; Kamikura DM; Cooper JA; Bernstein ID
Blood; 2005 Feb; 105(3):1295-302. PubMed ID: 15454492
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
12. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C in the phosphorylation of CD33 (Siglec-3) and its effect on lectin activity.
Grobe K; Powell LD
Blood; 2002 May; 99(9):3188-96. PubMed ID: 11964282
[TBL] [Abstract][Full Text] [Related]
14. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
16. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
[TBL] [Abstract][Full Text] [Related]
17. Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.
Lajaunias F; Dayer JM; Chizzolini C
Eur J Immunol; 2005 Jan; 35(1):243-51. PubMed ID: 15597323
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.
Fasen K; Cerretti DP; Huynh-Do U
Traffic; 2008 Feb; 9(2):251-66. PubMed ID: 18034775
[TBL] [Abstract][Full Text] [Related]
20. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.
Cornish AL; Freeman S; Forbes G; Ni J; Zhang M; Cepeda M; Gentz R; Augustus M; Carter KC; Crocker PR
Blood; 1998 Sep; 92(6):2123-32. PubMed ID: 9731071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]